Floxuridine hepatic arterial infusion associated biliary toxicity is increased by concurrent administration of systemic bevacizumab.
第一作者:
Andrea,Cercek
第一单位:
Department of Solid Tumor Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA, cerceka@mskcc.org.
作者:
医学主题词
抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);胆管肿瘤(Bile Duct Neoplasms);胆管, 肝内(Bile Ducts, Intrahepatic);癌, 肝细胞(Carcinoma, Hepatocellular);胆管上皮癌(Cholangiocarcinoma);临床试验, Ⅱ期(主题)(Clinical Trials, Phase II as Topic);结直肠肿瘤(Colorectal Neoplasms);女(雌)性(Female);氟尿苷(Floxuridine);随访研究(Follow-Up Studies);肝动脉(Hepatic Artery);人类(Humans);高胆红素血症(Hyperbilirubinemia);输注, 动脉内(Infusions, Intra-Arterial);肝肿瘤(Liver Neoplasms);男(雄)性(Male);中年人(Middle Aged);肿瘤分期(Neoplasm Staging);预后(Prognosis);前瞻性研究(Prospective Studies);随机对照试验(主题)(Randomized Controlled Trials as Topic)
DOI
10.1245/s10434-013-3275-0
PMID
24154839
发布时间
2017-10-11
- 浏览9
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



